Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Pharmacy Technician
Pharmacy Week
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Epilepsy
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Huntington's Disease
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Shingles
Transplant
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
INFECTIOUS DISEASE
October 17, 2024
Chloroquine Phosphate 16.7 mg/mL Oral Suspension
In addition to preventing and treating malaria, this preparation may be used to manage amebiasis and some inflammatory conditions.
October 17, 2024
Doxycycline Guidelines for STI Postexposure Prophylaxis
October 17, 2024
The Pharmacist’s Role in Antimicrobial Stewardship
October 17, 2024
Novel Strategy for Preventing Cardiovascular Disease in Patients With HIV
October 17, 2024
New Drug Review 2024
August 16, 2024
Measles
August 16, 2024
Treating Pediatric and Adolescent Impetigo
August 16, 2024
Managing Hospitalized Pediatric Patients With Influenza
August 16, 2024
Group A Streptococcus Treatment and Management
August 7, 2024
Variability in Reported RSV Incidence Among Adults
August 7, 2024
Broad-Spectrum Antibiotic Use in Community-Onset Sepsis
August 7, 2024
Treating Antimicrobial-Resistant Bacterial Infections
July 18, 2024
Flucytosine 50 mg/mL Oral Suspension
Load More
X
October 2024
In This Issue
Archives
Subscription
×
Full Image